Navigation Links
ViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
Date:7/18/2014

CLEVELAND, July 18, 2014 /PRNewswire/ -- ViewRay™ Incorporated, a privately held medical device company, will be featuring its MRIdian™ (me-rid-i-an) system in booth 639 at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX.

The MRIdian system – the world's first and only MRI-guided radiation therapy system – is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous Magnetic Resonance Imaging (MRI) and radiation therapy delivery. With continuous soft-tissue imaging, clinicians can clearly see the cancer target, monitor where the actual radiation dose is being delivered, and adapt to changes in the patient's anatomy – all in real time, providing a more precise and personalized cancer treatment option.

AAPM, the largest association of medical physicists in the world, has selected six "hot topics" for its 2014 annual meeting, including MRI-guided radiation therapy. The topic will be highlighted in several tracks during the conference including a session titled MRI in the Treatment Room, featuring early adopters of the MRIdian system from Siteman Cancer Center and Washington University School of Medicine, which will be held on Wednesday, July 23, at 4:30 p.m. in Room 17A.  Ten abstracts from Siteman focused on research with the MRIdian system have been selected for oral and poster presentations at this year's meeting. For a comprehensive look at AAPM 2014 sessions, download the meeting program here.

First patient treatments on the MRIdian system began in January of 2014 at the Siteman Cancer Center in St. Louis, Mo. Since the launch of its MRI-guided RT program, the center has treated a wide array of disease sites including breast, bladder, lung, pancreas and stomach. Clinical applications experts from ViewRay will be available in booth 639 at AAPM to demonstrate treatment planning and delivery functionality of the system.

About ViewRay
ViewRay Incorporated of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. The MRIdian (me-rid-i-an) system provides continuous soft-tissue imaging during treatment, using MRI-guided radiotherapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. For more information, visit http://www.viewray.com.

ViewRay and MRIdian are trademarks of ViewRay Incorporated.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.


'/>"/>
SOURCE ViewRay
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
2. Siteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with First ViewRay System
3. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
4. CIVCO to Showcase Protura and Varian Interface at AAPM 2014
5. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
6. NW Bio To Present At Biotech Showcase 2014
7. Soligenix to Present at the 2014 Biotech Showcase in San Francisco
8. G1 Therapeutics to Present at Biotech Showcase 2014
9. Salutron, Inc. Showcases Benefits of Heart Rate Measurement in Activity Monitoring at ShowStoppers and CES 2014
10. Aethlon Medical to Present at Biotech Showcase Investor Conference
11. BioLineRx to Present at Biotech Showcase Conference in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... --  Fourth-quarter 2016 revenues of ... to top end of guidance ... in fourth-quarter 2016 associated with the write-down of goodwill ... reporting unit Fourth-quarter reported ... Full-year 2016 reported $14.48 diluted (GAAP) loss per share ...
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... Feb. 27, 2017   Vitasome ® Labs ... supplements using its groundbreaking new liposome technology. Whereas vitamins ... potency through digestion per Physician,s Desk Reference , ... problem of nutritional waste and are scientifically formulated to: ... processes Improve bioavailability with a vastly ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the problem ... on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription ... fatal overdoses in male populations.(1) , The proportion of women using illicit drugs is ...
(Date:2/27/2017)... ... 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working ... nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. , ... is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):